Alector (ALEC) Revenue Growth (1y) (2019 - 2026)
Alector (ALEC) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 96.43% |
| 10 | Alector | 168.10 Mn | -38.42 Mn | - | -71.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.53% |
| Dec 31, 2025 | -88.50% |
| Sep 30, 2025 | -78.75% |
| Jun 30, 2025 | -47.80% |
| Mar 31, 2025 | -76.88% |
| Dec 31, 2024 | 257.08% |
| Sep 30, 2024 | 68.43% |
| Jun 30, 2024 | -73.17% |
| Mar 31, 2024 | -3.96% |
| Dec 31, 2023 | 5.19% |
| Sep 30, 2023 | -38.67% |
| Jun 30, 2023 | -29.60% |
| Mar 31, 2023 | -32.38% |
| Dec 31, 2022 | 3.19% |
| Sep 30, 2022 | -91.86% |
| Jun 30, 2022 | 1,115.76% |
| Mar 31, 2022 | 495.47% |
| Dec 31, 2021 | 188.36% |
| Sep 30, 2021 | 2,989.65% |
| Jun 30, 2021 | 107.19% |